绝经后乳腺癌雄激素受体表达_副本.pdfVIP

NIH Public Access Author Manuscript Clin Cancer Res. Author manuscript; available in PMC 2012 April 1. N Published in final edited form as: I H Clin Cancer Res. 2011 April 1; 17(7): 1867–1874. doi:10.1158/1078-0432.CCR-10-2021. - P A A u Androgen Receptor Expression and Breast Cancer Survival in t h o r Postmenopausal Women M a n 1 2 1,5 3 u Rong Hu , Shaheenah Dawood , Michelle D. Holmes , Laura C. Collins , Stuart J. s 3 3 3 1,5 c Schnitt , Kimberley Cole , Jonathan D. Marotti , Susan E. Hankinson , Graham A. r 4,5 1,5 i p Colditz , and Rulla M. Tamimi t 1 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School 2 Department of Breast Medical Oncology, Dubai Hospital 3 Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School 4 Department of Surgery, Washington University School of Medicine N I H 5 Department of Epidemiology, Harvard School of Public Health - P A Abstract A u t Purpose—Androgen receptor (AR) is commonly expressed in breast cancers. However, the h o association between tumor AR status and breast cancer survival is uncertain. Hence, we examined r M the association between AR status and breast cancer survival in the Nurses’ Health Study (NHS). a n Experimental Design—It was a pros